IRR and 95% CIs of outpatient visits (excluding routine follow-up visits for lymphoma) and inpatient visits and bed days during follow-up (from 1 year after diagnosis)
| . | IRR; 95% CI∗ . | |||
|---|---|---|---|---|
| Total . | 1-5 y after diagnosis . | 5-10 y after diagnosis . | >10 y after diagnosis . | |
| Outpatient visits | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 2.0; 1.8-2.2 | 2.2; 2.0-2.5 | 2.1; 1.8-2.4 | 1.4; 1.1-1.8 |
| Comparators | 0.6; 0.5-0.6 | 0.5; 0.4-0.6 | 0.5; 0.4-0.6 | 0.6; 0.4-0.8 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.2; 1.0-1.5 | 1.3; 1.0-1.6 | 1.1; 0.8-1.4 | 0.7; 0.5-1.1 |
| Inpatient visits | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 7.2; 6.3-8.3 | 8.7; 7.3-10.3 | 4.6; 3.7-5.8 | 2.6; 1.8-3.7 |
| Comparators | 0.1; 0.1-0.2 | 0.1; 0.1-0.1 | 0.2; 0.1-0.2 | 0.3; 0.2-0.5 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.0; 0.7-1.3 | 1.0; 0.7-1.4 | 0.6; 0.4-0.9 | 0.5; 0.2-0.9 |
| Bed days | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 8.3; 6.8-10.1 | 10.0; 7.7-13.0 | 5.2; 3.7-7.3 | 4.1; 2.4-6.9 |
| Comparators | 0.1; 0.1-0.2 | 0.1; 0.1-0.1 | 0.2; 0.1-0.3 | 0.2; 0.1-0.4 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.1; 0.7-1.6 | 1.1; 0.7-1.9 | 0.8; 0.4-1.5 | 0.7; 0.3-2.1 |
| . | IRR; 95% CI∗ . | |||
|---|---|---|---|---|
| Total . | 1-5 y after diagnosis . | 5-10 y after diagnosis . | >10 y after diagnosis . | |
| Outpatient visits | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 2.0; 1.8-2.2 | 2.2; 2.0-2.5 | 2.1; 1.8-2.4 | 1.4; 1.1-1.8 |
| Comparators | 0.6; 0.5-0.6 | 0.5; 0.4-0.6 | 0.5; 0.4-0.6 | 0.6; 0.4-0.8 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.2; 1.0-1.5 | 1.3; 1.0-1.6 | 1.1; 0.8-1.4 | 0.7; 0.5-1.1 |
| Inpatient visits | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 7.2; 6.3-8.3 | 8.7; 7.3-10.3 | 4.6; 3.7-5.8 | 2.6; 1.8-3.7 |
| Comparators | 0.1; 0.1-0.2 | 0.1; 0.1-0.1 | 0.2; 0.1-0.2 | 0.3; 0.2-0.5 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.0; 0.7-1.3 | 1.0; 0.7-1.4 | 0.6; 0.4-0.9 | 0.5; 0.2-0.9 |
| Bed days | ||||
| Comparators | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| MCL | 8.3; 6.8-10.1 | 10.0; 7.7-13.0 | 5.2; 3.7-7.3 | 4.1; 2.4-6.9 |
| Comparators | 0.1; 0.1-0.2 | 0.1; 0.1-0.1 | 0.2; 0.1-0.3 | 0.2; 0.1-0.4 |
| non–HD-ASCT | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
| HD-ASCT† | 1.1; 0.7-1.6 | 1.1; 0.7-1.9 | 0.8; 0.4-1.5 | 0.7; 0.3-2.1 |